Biotechnology Jobs

• Stevenage
• US$188,100 – US$313,500 pa
• Director

Lead end-to-end application of Model-Informed Drug Development across the drug development lifecycle, from first-in-human studies through filing and lifecycle management, providing clinical pharmacology strategy and evidence generation. Draft and review regulatory content for FDA, EMA, CDE, PMDA and ICH, and build cross-functional partnerships across digital medicine, translational imaging, AI/ML and biostatistics. The role sits in the newly established Clinical Pharmacology and Quantitative Medicine organisation, reporting into the Respiratory, Immunology & Inflammation Research Unit.

MIDD · QSP · AI/ML

• Durham, United States
• US$188,100 – US$313,500 pa
• Director

Leads end-to-end application of Model-Informed Drug Development and clinical pharmacology strategy across the drug development lifecycle, from first-in-human studies through filing and lifecycle management. Partners with digital medicine, translational imaging, modelling and biostatistics teams, and drafts regulatory content for FDA, EMA, CDE, PMDA and ICH submissions. Based in the newly formed Clinical Pharmacology and Quantitative Medicine organisation, with a strong publication and scientific leadership remit.

MIDD · QSP · AI/ML

• Waltham, United States
• Hybrid
• US$204,000 – US$340,000 pa
• Director

Leads the design and execution of real-world evidence and health outcomes studies for oncology assets, managing timelines, budgets and quality of protocols, analyses and publications. Advises internal medical, market access and commercial teams and external experts on evidence strategy for HTA submissions, reimbursement and value-based pricing. Requires close collaboration across a matrix and deep knowledge of real-world data sources and payer needs.

• London
• Hybrid
• US$204,000 – US$340,000 pa
• Director

Leads the design and execution of real-world evidence and health outcomes studies across oncology assets, managing timelines, budgets and quality of protocols, analyses and publications. Advises internal medical, market access and commercial teams and external experts on evidence strategy for HTA submissions, reimbursement and value-based pricing, while building knowledge of real-world data sources and payer needs.

• Rockville Tower Oaks Blvd
• Hybrid
• US$204,000 – US$340,000 pa
• Director

Leads the design and delivery of real-world evidence and health outcomes studies across oncology assets, managing protocols, budgets, timelines and vendor deliverables. Partners with medical, market access, R&D and commercial teams plus external experts to shape evidence for HTA submissions, reimbursement and value-based pricing. Requires deep knowledge of RWD sources and payer evidence requirements.

• Durham Blackwell Street
• Hybrid
• US$204,000 – US$340,000 pa
• Director

Leads the design and delivery of real-world evidence and health outcomes studies for oncology assets, managing protocols, budgets, vendors and reporting from concept to publication. Advises medical, market access and commercial teams on payer and HTA evidence needs, and builds relationships with external experts and data partners.

• Waltham, United States
• On-site
• US$242,550 – US$404,250 pa
• Director · manages people

Senior physician leader providing medical oversight, safety monitoring and clinical data interpretation across lung cancer studies within a clinical programme team. Partners with the Senior Scientist and cross-functional matrix teams on protocol design, regulatory interactions and external scientific engagement, while mentoring Medical Directors. Requires an on-site presence at least two days a week at a GSK site in Switzerland, the UK or the US.

• Stevenage
• On-site
• US$242,550 – US$404,250 pa
• Director · manages people

Senior physician leader providing medical oversight, safety evaluation and clinical data interpretation across lung cancer studies within a clinical programme team. Partners with the Senior Scientist and cross-functional Clinical Matrix Team on protocol design, regulatory interactions and external scientific engagement, while mentoring Medical Directors. Requires deep lung cancer drug development expertise including early phase trials.

• Zug, Switzerland
• On-site
• US$242,550 – US$404,250 pa
• Director · manages people

Senior physician leader providing medical oversight, safety evaluation and clinical data interpretation across lung cancer studies within a clinical programme team. Partners with the Senior Scientist and cross-functional groups on protocol design, regulatory interactions and external scientific engagement, while mentoring Medical Directors. Requires an on-site presence of at least two days a week at a GSK site.

• Waltham, United States
• Hybrid · 2–3 days in office
• US$222,750 – US$371,250 pa
• Director

Serves as the physician on oncology clinical programme teams for lung and head/neck cancers, leading medical monitoring, safety oversight and clinical data interpretation across Phase I–III studies. Partners with a Senior Scientist and cross-functional matrix teams on protocol development, regulatory interactions and investigator engagement, with on-site presence 2–3 days per week.

AI

• Stevenage
• On-site
• US$222,750 – US$371,250 pa
• Director

Serves as the physician within oncology clinical programme teams for lung and head/neck cancers, leading medical monitoring, safety oversight and clinical data interpretation. Partners with the Senior Scientist and cross-functional Clinical Matrix Team on protocol development, regulatory interactions and investigator engagement, with on-site presence 2-3 days per week.

AI-enabled insights

• Zug, Switzerland
• On-site
• US$222,750 – US$371,250 pa
• Director

Serves as the physician within oncology clinical programme teams for lung and head/neck cancers, leading medical monitoring, safety oversight and clinical data interpretation. Partners with the Senior Scientist and cross-functional teams on protocol development, regulatory interactions and investigator engagement, with on-site presence 2-3 days per week.

AI-enabled insights

• London
• On-site
• US$222,750 – US$371,250 pa
• Director

Serves as the physician within oncology clinical programme teams for lung and head/neck cancers, leading medical monitoring, safety oversight and clinical data interpretation across Phase I–III studies. Partners with Senior Scientists and cross-functional matrix teams on protocol development, regulatory interactions and investigator engagement, with on-site presence 2–3 days per week.

AI

• Mississauga, Canada
• On-site
• US$222,750 – US$371,250 pa
• Director

Serves as the physician within oncology clinical programme teams, leading medical monitoring and safety oversight for lung and head/neck cancer studies. Interprets clinical and safety data, contributes to protocol development, and engages investigators, regulators and cross-functional matrix teams across Phase I–III development.

• London
• On-site
• US$284,250 – US$473,750 pa
• Director

Leads clinical development of oncology assets in genitourinary cancers, overseeing Phase 1-3 interventional trials from protocol design through final study report. Provides real-time medical monitoring, safety review with pharmacovigilance, and regulatory document authoring, while building relationships with key external experts. Serves as a core member of the Clinical Matrix Team and contributes to disease area strategy and business development diligence.